1. Home
  2. BLND vs CDNA Comparison

BLND vs CDNA Comparison

Compare BLND & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$3.07

Market Cap

894.7M

Sector

Technology

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.32

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLND
CDNA
Founded
2012
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
894.7M
712.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLND
CDNA
Price
$3.07
$19.32
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$4.80
$26.67
AVG Volume (30 Days)
3.4M
841.8K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$167,532,000.00
$357,998,000.00
Revenue This Year
N/A
$14.11
Revenue Next Year
$19.81
$12.00
P/E Ratio
N/A
$16.01
Revenue Growth
37.61
14.46
52 Week Low
$2.50
$10.96
52 Week High
$4.83
$25.95

Technical Indicators

Market Signals
Indicator
BLND
CDNA
Relative Strength Index (RSI) 46.31 60.43
Support Level $3.01 $19.21
Resistance Level $3.15 $20.05
Average True Range (ATR) 0.14 0.89
MACD -0.01 -0.07
Stochastic Oscillator 16.67 61.97

Price Performance

Historical Comparison
BLND
CDNA

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: